Triethyl phosphonoacetate → ethyl (RS)-[3-oxo-2-(2,2,2-trifluoroethyl)-6-trifluoromethyl-2,3-dihydro-1H-isoindol-1-yl]acetate
Reaction equation
C(OP([CH2:9][C:10]([O:12][CH2:13][CH3:14])=[O:11])(OCC)=O)C.[H-].[Na+].O[CH:18]1[C:26]2[C:21](=[CH:22][CH:23]=[C:24]([C:27]([F:30])([F:29])[F:28])[CH:25]=2)[C:20](=[O:31])[N:19]1[CH2:32][C:33]([F:36])([F:35])[F:34].C(=O)([O-])O.[Na+]>C(COC)OC>[O:31]=[C:20]1[C:21]2[C:26](=[CH:25][C:24]([C:27]([F:28])([F:29])[F:30])=[CH:23][CH:22]=2)[CH:18]([CH2:9][C:10]([O:12][CH2:13][CH3:14])=[O:11])[N:19]1[CH2:32][C:33]([F:35])([F:34])[F:36]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
Under argon, ethyl (diethoxyphosphoryl)acetate (135 mg, 0.6 mmol) was dissolved in anhydrous dimethoxyethane (10 ml). 17.6 mg of NaH (60% in oil) were added at RT to this solution which was stirred at RT for 10 min. Afterward, a solution of 120 mg (0.04 mmol) of (RS)-3-hydroxy-2-(2,2,2-trifluoroethyl)-5-trifluoromethyl-2,3-dihydroisoindol-1-one in anhydrous dimethoxyethane (5 ml) was added and the mixture was subsequently stirred at reflux for 2 h. The reaction solution was left to cool; the reaction solution was then poured onto 50 ml of 5% sodium hydrogencarbonate solution and extracted twice with 20 ml each time of ethyl acetate; the organic phase was dried over MgSO4 and concentrated under reduced pressure, and the residue was purified by chromatography on silica gel using DIP as the eluent. 90 mg (61%) of ethyl (RS)-[3-oxo-2-(2,2,2-trifluoroethyl)-6-trifluoromethyl-2,3-dihydro-1H-isoindol-1-yl]acetate were obtained as a colorless oil which crystallized from heptane as a beige solid.
Workup
- stirringthe mixture was subsequently stirred
- temperatureat reflux for 2 h
- waitThe reaction solution was left
- temperatureto cool
- extractionextracted twice with 20 ml each time of ethyl acetate
- dry with materialthe organic phase was dried over MgSO4
- concentrationconcentrated under reduced pressure
- customthe residue was purified by chromatography on silica gel using DIP as the eluent
Sources & evidence
- ORD record
- ord-31a2bcd96093423781317262670801f4
- Source dataset
- uspto-grants-2012_10
- Patent number
- US08283374B2
Reaction notes
Loading…